Doctor Sachie Kasukabe

Tohoku University, Sendai (Japan)

Membership: ESC Professional Member

Follow

Contributor content

Impact of baseline C-reactive protein on the efficacy and safety of rivaroxaban monotherapy in atrial fibrillation and stable coronary artery disease: a post-hoc AFIRE analysis

Presentation

Impact of baseline C-reactive protein on the efficacy and safety of rivaroxaban monotherapy in atrial fibrillation and stable coronary artery disease: a post-hoc AFIRE analysis

ESC 365 is supported by

novartis

Explore sponsored resources